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Abstract
Background: Quality improvement in high-acuity surgery increasingly relies on clinical pathways to
streamline patient care and to maximize cost-efficiency. Yet, it remains unclear whether immediate
pre-operative hospitalization (non-elective resection) influences operative performance and to what
extent it alters the post-operative course.
Methods: Retrospective case series, cost analysis.University tertiary care referral centre. Four hundred
and twelve consecutive pancreatic resections performed for benign and malignant disease between 2001
and 2008. Outcomes for both elective and non-elective operations were scrutinized, and correlated with
deviations from our clinical Carepath for Pancreatic Resection. Observed-to-expected (O/E) morbidity
ratios were calculated for each.
Results: Overall, 39 patients (10%) required immediate pre-operative hospitalization, 22 (56%) of which
were transferred from another hospital. The most common indications were pancreatitis, gastric outlet
obstruction, intractable abdominal pain and gastrointestinal bleeding. During a 1- to 2-week hospitaliza-
tion, 51% of patients underwent endoscopic retrograde cholangio-pancreatography (ERCP), 36% were
administered parenteral nutrition, 20% received antibiotics and 15%were transfused blood products. Yet,
this pre-operative scenario, at a median cost of $7250 per patient, had no measurable impact on
operative performance. Post-operatively, non-elective patients suffered more complications and a higher
(O/E) ratio (1.00 vs. 0.93). These outcomes resulted in significantly more deviations from our carepath and
an additional $7000 per non-elective case.
Conclusion: Immediate pre-operative hospitalization has no meaningful impact on operative perfor-
mance; yet, deviations from a standardized clinical pathway are far more likely after non-elective pan-
creatic resection, and result in more severe clinical and economic outcomes.
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Introduction
Quality improvement is an emerging trend, particularly in high-
acuity surgery, where comorbid conditions are the norm, opera-
tions are technically demanding, and complications are caustic
and costly. Traditional process and systems improvements have
thus far focused considerably on high volume thresholds and
selective regionalization of surgical care, particularly for
pancreatic resection and other high-acuity operations.1–7
However, these initiatives are imprecise and mask the underlying
factors that may contribute to better outcomes. Recent data sug-
gests that many high-volume surgical specialty centres utilize
clinical pathways to streamline patient care and to maximize cost-
efficiency.8–11 A clinical pathway defines an effective care process
for a particular diagnosis or procedure based on evidence-based
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guidelines, and establishes the optimal sequence and timing of
interventions by health care providers. Its primary aims are to
standardize and improve the quality of patient care, to minimize
resource utilization, to shorten hospital stays and to increase cost-
effectiveness.12 Today, these clinical pathways are increasingly
relied upon to improve quality and deliver better peri-operative
outcomes in pancreatic surgery.13–15
Through the collaborative efforts of a dedicated multi-service,
specialty team of surgeons, gastroenterologists, anaesthesiologists,
pathologists, radiologists, nurses and hospital administrators, a
detailed clinical pathway for peri-operative management was
recently implemented at our institution. This pathway outlines a
standardized management approach for all patients undergoing
pancreatic resection based on the tenants of evidence-based medi-
cine. It provides simple guidelines for the management and timely
removal of central venous catheters, nasogastric tubes, urinary
catheters and intra-abdominal drains; it standardizes peri-
operative fluid resuscitation, antibiotic administration, diagnostic
testing and initiation of oral intake; finally, it incorporates several
patient-centred initiatives, including psychosocial counselling,
geriatric consultation and early rehabilitation planning whenever
indicated.6,15
Today, pancreatic resection is typically performed as an elective
operation, usually after a detailed diagnostic evaluation has been
conducted in the outpatient setting. However, a subset of patients
still requires immediate pre-operative hospitalization (and conse-
quent non-elective resection) for periampullary neoplasms, pan-
creatitis or cystic conditions that are associated with additional
peripancreatic complications (i.e. gastric outlet obstruction,
malignant biliary obstruction, malnutrition, hypovolemia, gas-
trointestinal and intra-abdominal bleeding). While most clinical
pathways seek to streamline patient care, to minimize resource
utilization and to facilitate early discharge, it remains unclear
whether these outcomes can be achieved when patients require
immediate pre-operative hospitalization prior to pancreatic resec-
tion. Therefore, this study will describe the influence of pre-
operative hospitalization on operative performance, the extent to
which non-elective resection alters the post-operative clinical
course and the attendant costs incurred under the framework of a
standardized clinical pathway.
Methods
Patients
Two fellowship-trained pancreato-biliary surgical specialists
(M.P.C., C.M.V.) performed 412 consecutive pancreatic resections
between October 2001 and March 2008. Final pathological
diagnosis revealed a full spectrum of benign and malignant peri-
ampullary pathology, most commonly pancreatic ductal adeno-
carcinoma (n = 131), cystic neoplasm (n = 92) and chronic
pancreatitis (n = 61). Other conditions consisted of ampullary
adenocarcinoma (n = 34), neuroendocrine tumours (n = 31),
distal cholangiocarcinoma (n = 8), duodenal adenocarcinoma
(n = 6) and other benign (n = 42) or malignant (n = 7) conditions,
such as pancreatic or biliary ductal strictures, adenomas, gas-
trointestinal stromal tumours and metastatic renal cell carcinoma.
Operations
All pancreatic resections were performed in a reproducible
fashion at our institution; these included 272 pancreatoduodenec-
tomies and 124 distal, 9 central and 7 total pancreatectomies.
Specific modifications, including technical approaches and man-
agement of the pancreatic remnant, have been described in prior
studies.16,17 Pancreatoduodenectomy was frequently performed
for pancreatic ductal adenocarcinoma (40%). The most common
indications for distal pancreatectomy were cystic neoplasms
(44%), primarily intraductal papillary mucinous neoplasia
(IPMN) and mucinous cystadenoma (33% and 37% of cystic
neoplasms, respectively). Central pancreatectomy was also per-
formed for cystic neoplasms (44%). Total pancreatectomy was
usually performed for patients with pancreatic ductal adenocar-
cinoma in the setting of IPMN (71%).
Clinical pathway
All aspects of care were directed by the operating surgeon accord-
ing to a standardized Carepath for Pancreatic Resection employed
at our institution.6,15 This pathway outlines a standardized multi-
disciplinary management approach for all patients, and provides a
detailed plan for preoperative assessment and preparation, throm-
boembolic and antibiotic prophylaxis, peri-operative pain man-
agement, as well as the removal of central venous catheters,
nasogastric tubes, urinary catheters and intra-abdominal drains.
Furthermore, this clinical pathway standardizes patients’ peri-
operative fluid resuscitation and alimentation, and minimizes
diagnostic and laboratory testing. Finally, the pathway incorpo-
rates several patient-centred initiatives and provides psychosocial
counselling, nutrition consultation, input from medical pancrea-
tologists and early rehabilitation planning whenever indicated.
Data collection
In accordance with guidelines for human subjects research,
approval was obtained from the Institutional Review Board at
Beth Israel Deaconess Medical Center. Data on pre-operative,
intra-operative and post-operative care were prospectively col-
lected for each case. Pre-operative parameters included patient
demographics, presenting symptoms, comorbidities, American
Society of Anesthesiologists (ASA) classification of physical sta-
tus,18 vital signs, laboratory tests, nutritional parameters (i.e.
albumin, serum glucose), prior imaging studies and any other
diagnostic or therapeutic studies performed. Expected morbidity
for each patient was estimated for each of the 412 patients in
accordance with the Physiologic and Operative Severity Score for
the enUmeration of Mortality and Morbidity (POSSUM score).19
Intra-operative variables included total operative time, blood loss,
fluid administration, transfusion of blood products, anastomotic
technique, as well as the use of drains, stents and pharmacological
adjuvants. Final disease pathology was determined and reported
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to the patient within 1 week following each case. Periampullary
(i.e. pancreatic, ampullary, distal common bile duct, duodenal)
adenocarcinomas, IPMN with carcinoma in situ or invasive malig-
nancy and other metastatic lesions were classified as malignant
conditions. Inflammatory disease (i.e. pancreatitis and stricture),
periampullary adenomas, IPMN with low- or moderate-grade
dysplasia, serous and mucinous cystadenoma and non-invasive
neuroendocrine tumours were considered benign conditions.
Post-operative events and clinical outcomes were prospectively
recorded by an independent research associate. Hospital costs for
each patient were obtained using the institution’s Casemix TSI
data system.
Pre-operative hospitalization
Two distinct clinical presentations manifest based on the level of
urgency prior to pancreatic resection. Elective pancreatic resec-
tions are performed for those patients, who undergo a detailed
diagnostic evaluation in the outpatient setting, and who then
present on the day of the index operation for definitive manage-
ment of periampullary lesions. These clinical presentations are
appropriately referred to as ‘Elective Resections’. In some circum-
stances, these elective patients initially present elsewhere, prior to
referral to our specialty unit for definitive management.
In contrast, there exists a subset of patients that requires hos-
pitalization immediately prior to pancreatic resection. Some
patients may also present elsewhere initially, but are eventually
transferred and admitted to our institution for further evaluation.
These patients typically undergo inpatient diagnostic evaluations,
as well as therapeutic intervention for complications related to
their underlying periampullary conditions. Indications include,
but are not limited to, gastric outlet obstruction, pancreatitis,
malnutrition, gastrointestinal bleeding, obstructive jaundice and
cholangitis. When these conditions occur, subsequent diagnostic
evaluation (i.e. laboratory and radiological) and therapeutic inter-
vention (i.e. antibiotics, supplemental nutrition, blood transfu-
sion, endoscopic and/or image-guided approaches) is required.
Patients with this presentation eventually proceeded to ‘Non-
Elective Resections’, performed several days after hospital admis-
sion, but during the index hospitalization at our institution.
Analysis of pre-operative hospitalization
Clinical and economic impact
Three distinct outcomes analyses were performed to reveal the
incremental impact of immediate pre-operative hospitalization
on operative performance and the extent to which non-elective
resection alters the post-operative clinical course. The first analy-
sis examines and compares clinical and economic outcomes for
the Elective and Non-Elective groups. Traditional indicators of
quality – complications, hospital duration and operative mortality
– were scrutinized, as well as other emerging measures of surgical
quality: therapeutic and invasive interventions, ICU utilization,
patient discharge disposition and hospital readmission rates. Post-
operative complications after elective and non-elective resections
were graded by an independent reviewer according to the Clavien
complication scheme.20 Similarly, costs accrued before and after
surgical intervention were examined for both patient cohorts.
These include total and itemized cost metrics, which have been
defined elsewhere.16 Pre-operative hospital costs refer to those
costs incurred during the pre-operative hospitalization period
and exclude any costs for outpatient diagnostic evaluations. Post-
operative hospital costs are defined as those incurred during the
index operation, during the post-operative period up to hospital
discharge, plus any costs incurred during readmissions within 30
days of hospital discharge. Total hospital costs are the aggregate of
pre-operative and post-operative hospital costs.
As mentioned above, the incidence and severity of post-
operative complications were defined according to the Clavien
complication scheme, a reliable and previously validated tool for
surgical quality assessment.20,21 This system describes five grades
of clinical severity, based not on duration of stay in the hospital,
but rather on the distinction of escalating levels of therapeutic
interventions required to treat adverse events. Briefly, ‘Minor’
complications (i.e. Clavien Grades I and II) correspond to any
deviation from the normal post-operative course, which may or
may not require pharmacological treatment, including antiemet-
ics, antipyretics, analgesics, diuretics, electrolytes, therapeutic
physiotherapy, blood transfusions, total parental nutrition, anti-
biotics or anticoagulants. ‘Moderate’ complications (i.e. Clavien
Grade III-A) represent those adverse events that require radiologi-
cal or endoscopic intervention. ‘Major’ complications (i.e. Clavien
Grades III-B, IV, V) are more variable, but refer to those that
necessitate surgical intervention, are life-threatening and/or result
in death. These complication categories have been described in
more detail in a prior study.15
Observed-to-expected morbidity
The second outcomes analysis estimates further the clinical
impact of immediate pre-operative hosptitalization and subse-
quent non-elective resection. Details of this novel analysis have
been previously published.6 In summary, differences in patient
acuity (i.e. baseline physiology) for the elective and non-elective
groups were directly correlated with observed surgical outcomes
to reflect the impact of the non-elective scenario on outcomes.
Specifically, we compared the actual number of complications
incurred to the predicted number of complications – the
observed-to-expected (O/E) morbidity ratio – for each patient
cohort.
Expected morbidity was predicted for each of the 412 patients
based on the POSSUM score. This measure of patient acuity has
been validated as a reliable scoring system for estimating morbid-
ity risk in high-acuity surgery, particularly pancreatic resec-
tion.19,22 The risk of developing a post-operative complication
(from 0% to 100%) was predicted for each individual patient
using the POSSUM score equation. The ‘Expected Morbidity’ for
our practice overall, as well that for elective and non-elective
resections, was then estimated by calculating the mean POSSUM
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score for the cohort assessed. The actual incidence of post-
operative complications (‘Observed Morbidity’) was also deter-
mined for all patients undergoing pancreatic resection within our
practice and by resection groups, using the aforementioned
Clavien complication scheme.20 Using the actual incidence of
post-operative complications and the mean POSSUM score, O/E
morbidity ratios were calculated for elective and non-elective
resections. These ratios provide a measure of variance in patient
outcomes and reveal areas for process and systems improvement.
Ratios equal to 1.00 demonstrate expected, on par, performance.
Ratios greater than 1.00 suggest outcomes are worse than
expected. Conversely, ratios less than 1.00 suggest outcomes
achieved are better than expected.
Deviation-based cost modelling
Peri-operative management for all patients was governed by a
standardized Carepath for Pancreatic Resection employed at our
institution. Surgical care beyond this baseline process was pro-
vided at the discretion of the operating surgeon whenever adverse
events or complications mandated further intervention for the
benefit of the patient. These deviations (i.e. departures from the
expected clinical course) were scrutinized in detail vis à vis
deviation-based cost modelling (DBCM).15
DBCM specifically merges complication severity with specific
duration of stay criteria. When peri-operative management
according to our carepath is achieved, ‘On-Course’ patients either
incur no adverse events or suffer only minor complications (i.e.
Clavien Grades I or II) and remain hospitalized for only 8 or fewer
days after their resections. ‘Minor Deviations’ represent patients,
who experience marginal increases in hospital duration (9 to 12
days), despite having – at most – only minor complications. ‘Mod-
erate Deviations’ result if patients require additional management
beyond 13 days or if moderate complications (i.e. Clavien Grade
III-A) occur irrespective of duration of stay. Finally, ‘Major Devia-
tions’ represent any circumstance in which major complications
(i.e. Clavien Grade III-b, IV, or V) occur, regardless of hospital
duration.
Hospital duration and costs for each deviation class were com-
pared between elective and non-elective resections using a
‘summary’ measure of cost-efficiency that combines the relative
proportion of each deviation category (on-course to major) with
its median hospital cost. This measure provides the weighted-
average median duration of stay and cost per patient, and reflects
the direct contribution of reducing complications to the overall
improvement of cost-effectiveness, as well as within each resection
group.
Statistical analysis
Categorical variables were compared using the chi-squared (c2,
Fischer’s exact tests,and univariate logistic regression statistics;
continuous variables were compared using analysis of variance
(anova), Student’s t-tests for independent variables and simple
linear regression when appropriate. Differences between observed
and expected morbidity were assessed with the c2 tests, using the
method described by Hosmer and Lemeshow to test the goodness
of fit.23 Factors associated with morbidity were calculated based
on cross-tabulations using chi-square statistic and Pearson’s cor-
relation test. Statistical significance for all analyses was accepted at
a P-value < 0.050. Statistical computations were performed using
Statistical Package for the Social Sciences 14.0 for Windows (SPSS,
Inc., Chicago, IL, USA) and STATA.8.2 for Windows (StataCorp
LP, College Station, TX, USA).
Results
Pre-operative hospitalization
Pancreatic resection was performed for 412 patients at our insti-
tution between October 2001 and March 2008. The majority
(90%) of patients had elective operations (n = 273) and did not
require any prior hospitalization; 39 patients (10%), however,
required pre-operative hospitalization at our institution directly
preceding their pancreatic resections. Males and females under-
went resection with relatively equal frequency in each patient
cohort. As anticipated, patients presenting for non-elective pan-
creatic resection were sicker, as judged by the ASA classification of
physical status and the POSSUM Physiologic Severity Score
(Table 1). This group largely consisted of patients transferred
Table 1 Pre-operative patient characteristics for patients undergoing
elective and non-elective pancreatic resection
Pre-operative
parameters
Elective
(n = 373)
Non-elective
(n = 39)
P-value
Age (median, years) 63 59 0.095
[23–90] [30–83]
Gender (%)
Male 174 (47) 20 (51) 0.350
Female 199 (53) 19 (49)
ASA physical status (%)
Class I 5 (1) 0 (0) 0.044
Class II 177 (48) 10 (26)
Class III 182 (49) 27 (69)
Class IV 9 (2) 2 (5)
Final pathology (%)a
Benign 191 (51) 24 (62) 0.144
Malignant 182 (49) 15 (38)
POSSUM – Physiological
Severity Score
19 22 0.023
[12–40] [13–34]
ASA, American Society of Anesthesiologists; POSSUM: Physiologic
and Operative Severity Score for the enUmeration of Mortality and
Morbidity.19
aMalignant: periampullary (i.e. pancreatic, ampullary, distal common bile
duct, duodenal) adenocarcinomas; intraductal papillary mucinous neo-
plasms (IPMN) with high-grade dysplasia, carcinoma in situ, or invasive
malignancy; other metastatic lesions. Benign: inflammatory disease (i.e.
pancreatitis and stricture); periampullary adenomas; IPMN with low- or
moderate-grade dysplasia; serous and mucinous cystadenoma; non-
invasive neuroendocrine tumors.
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from another hospital: 22 patients – 56% of non-elective and 5%
overall. The most common indications included pancreatitis (n =
14, 35%), gastric outlet obstruction (n = 9, 23%), intractable
abdominal pain (n = 6, 15%), gastrointestinal bleeding (n = 5,
13%) and jaundice (n = 4, 10%). One patient presented with
intractable hypoglycemia as a result of insulinoma. While the
majority (62%) of these non-elective patients had benign condi-
tions, a considerable proportion (38%) was eventually found to
harbour malignant tumours, a rate not significantly different from
that of the elective cohort (49%, P = 0.144).
Pre-operative hospitalization did not significantly alter patient
acuity, as measured by the POSSUM Physiologic Score. On admis-
sion, the acuity score for non-elective patients was 22 (median),
compared with 21 at the time of operative intervention (P =
0.601). During the in-patient process, 51% of patients (n = 20)
underwent endoscopic retrograde cholangiopancreatography
(ERCP) with biliary or pancreatic enteric drainage for unresolved
jaundice or failed drainage procedures; 36% (n = 14) were admin-
istered parenteral nutritional support; 20% (n = 8) received intra-
venous antibiotics; and 15% (n = 6) were transfused blood
products. These pre-operative interventions were typically pro-
vided during a 1- to 2-weeks hospitalization (median: 6 days,
range: 1–19 days) at a considerable cost (median: $7250; range:
$1201–$21 879).
Operative outcomes
Pancreatoduodenectomy, distal and central pancreatectomy were
performed with relatively equal frequency among elective and
non-elective patients; total pancreatectomy was not performed
in a non-elective fashion (Table 2). All operative outcomes were
equivalent between the two patient cohorts. Intra-operative blood
loss was similar during elective and non-elective resections – 350
and 400 ml, respectively – but, non-elective patients were trans-
fused intra-operatively more frequently (28% vs. 16%, P = 0.047).
Despite this approach, surgical performance, as judged by the
median POSSUM Operative Severity Score, was equal between the
patient cohorts (15 each). These findings indicate that despite
increased patient acuity for non-elective resections, this scenario
has no measurable impact on operative performance.
Post-operative outcomes
Overall
Clinical outcomes for all 412 patients met or exceeded current
benchmark standards for pancreatic resection.24,25 Overall, 216
patients (52%) developed complications of any severity; 102
patients (25%) had Grade I complications, 49 Grade II (12%), 39
Grade III (10%), 21 Grade IV (5%) and 5 Grade V (1.2%). Thus,
when complications occurred, the majority (70%) were of
minor severity (i.e. Clavien Grades I or II) – 151 patients in total
(37% overall) – and did not mandate any invasive or aggressive
Table 2 Operative outcomes for elective and non-elective pancreatic
resection
Intraoperative outcomesa Elective
(n = 373)
Non-elective
(n = 39)
P-value
Resection types (%)
Pancreatoduodenectomy 247 (66) 25 (64) 0.481
Distal pancreatectomy 112 (30) 12 (31)
Central pancreatectomy 7 (2) 2 (5)
Total pancreatectomy 7 (2)
Operative time (minutes)a 356 388 0.137
[76–780] [152–652]
Blood loss (ml)a 350 400 0.901
[0–15 000] [100–1800]
Blood transfusion (%) 59 (16) 11 (28) 0.047
POSSUM – operative
severity scoreb
15 15 0.798
[13–27] [13–23]
POSSUM: Physiologic and Operative Severity Score for the enUmeration
of Mortality and Morbidity.19
aAll continuous variables reflect the median for each cohort.
Table 3 Post-operative outcomes for elective and non-elective pan-
creatic resection
Postoperative
outcomesa
Elective
(n = 373)
Non-elective
(n = 39)
P-value
Morbidity (%) 190 (51) 26 (67) 0.043
Mortality (%) 5 (1.3) 0 (0) 0.607
Severity of complications
(%)
None 183 (49) 13 (33) 0.096
Minor 136 (36) 15 (38)
Moderate 28 (8) 5 (13)
Major 26 (7) 6 (15)
Therapeutic interventions
(%)
Antibiotics 102 (27) 16 (41) 0.056
Parenteral nutrition 36 (10) 10 (26) 0.006
Blood transfusion 59 (16) 11 (28) 0.047
Invasive interventions (%)
CT-guided percutaneous
drainage
19 (5) 2 (5) 0.611
Reoperation 15 (4) 5 (13) 0.031
ICU utilization (%) 15 (4) 16 (15) 0.009
Hospital duration (days)
Pre-operative 0 6 <0.001
Post-operative 8 9 0.007
Total 8 15 <0.001
Discharge disposition (%)
Home 320 (87) 33 (85) 0.417
Rehabilitation facility 48 (13) 6 (15)
Readmission (%) 53 (14) 8 (20) 0.202
aAll continuous variables reflect the median for each cohort.
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interventions. The remainder (30% of complicated patients, 16%
overall) suffered moderate or major complications (i.e. Clavien
Grades III, IV, or V).
Management in intensive care settings and reoperation were
seldom required (5% each), and only five patients overall (1.2%)
succumbed. The median post-operative hospital duration was 8
days (range: 1–61 days) and at the time of hospital discharge, 87%
of patients returned home, whereas 13% required additional care
in rehabilitation facilities. Hospital readmission (15%) was also
infrequent. These benchmark standards were achieved at a total
hospital cost of $18 136 per patient (median).
Non-elective resections
When non-elective pancreatic resections were performed, two-
thirds (n = 26) resulted in at least one complication of any sever-
ity; 39% of patients of this cohort suffered minor complications,
13% had moderate complications and 15% developed major com-
plications. The most common complications among this distinct
group included were oliguria/hypotension (38%), clinically rel-
evant pancreatic fistulae (20%), post-operative ileus (17%) and
wound infections (13%). The median post-operative hospital
duration for these resections was 9 days (range: 5–61). The major-
ity of patients, who required immediate pre-operative hospitaliza-
tion, returned home (85%) at the time of hospital discharge; 15%
required further management at rehabilitation facilities. Hospital
readmission occurred in 20% of cases and no perioperative deaths
were observed. The median post-operative cost for non-elective
resections was $22 674 (range: $13 951 to $46 610).
Elective versus non-elective
Clinical and economic outcomes were directly compared for
elective and non-elective pancreatic resections (Tables 3 and 4).
The overall incidence of post-operative complications was signifi-
cantly greater after non-elective resections compared with elective
cases (67% vs. 51%, P = 0.043). Deeper analysis of this scenario
reveals a trend towards more severe complications, as patients
who required an immediate pre-operative hospitalization were
more than twice as likely to develop moderate and/or major com-
plications (OR 2.32, 95% CI 1.09 to 4.94, P = 0.025). These
patients subsequently required more antibiotic therapy, supple-
mental parenteral nutritional support and blood transfusions
than patients who underwent elective resections. Similarly, more
aggressive interventions were mandated after non-elective resec-
tions, including reoperation and management in intensive care
settings; rates of CT-guided percutaneous drainage, however, were
equivalent between the groups. These outcomes ultimately
prolonged post-operative hospital stays, yet had no measurable
impact on hospital discharge disposition or readmission.
A detailed economic analysis was performed to determine the
incremental impact of non-elective resections. In sum, these
operations were associated with a total cost increase of $13 246 per
patient (median), the majority – $7250 or 55% – of which was as
a result of pre-operative management, whereas $5996 or 45% can
be attributed to differences in post-operative care. These costs
largely reflect increased rates of reoperation (i.e. OR costs) and
longer hospitalizations (i.e. room costs) after non-elective resec-
tions; all other cost metrics were not significantly different
between the groups.
Observed-to-expected morbidity
Given these distinct clinical and economic outcomes for non-
elective resections, a detailed quality analysis was conducted to
determine the extent to which these outcomes met or fell short of
benchmark standards for pancreatic resection. In summary,
observed morbidity was merged with expected,and compared
between the patient cohorts. ‘Expected’ morbidity (mean
POSSUM score) for all patients undergoing pancreatic resection
within our practice equaled 56.1% (Table 5). Thus, predictive risk
assessment estimated that 231 (of 412 total) patients would
develop at least one post-operative complication. This prediction
was accurate, as 216 patients actually developed a complication.
Consequently, the overall O/E morbidity ratio was 0.94 – margin-
ally better than expected.
Table 4 Economic outcomes for elective and non-elective pancre-
atic resection
Hospital costsa Elective Non-elective P-value
Radiology $339 $734 0.807
Laboratory $513 $684 0.407
Pharmacy $775 $1 308 0.707
Transfusion $134 $630 0.563
ICU $794 $1 293 0.867
Operating room $4 389 $4 920 0.036
Room $6 628 $9 891 0.013
Overall
Pre-operative – $7 250 –
Post-operative $17 963 $22 674 0.646
Total $17 963 $31 209 0.024
Total cost-increase – $13 246 –
aAll cost metrics reflect the median for each cohort.
Table 5 Observed-to-expected (O/E) Morbidity for elective and non-
elective pancreatic resections
Overall Elective Non-elective
Patients 412 373 39
Risk of complicationa 56.1% 54.7% 65.8%
Expected morbidity 231 204 26
Observed morbidityb 216 190 26
O/E morbidity ratio 0.94 0.93 1.00
aReflects mean POSSUM score for patient cohort.19
bRepresents actual incidence of complications according to the Clavien
complication scheme.20
c2 = 0.96; 1 d.f.; P = 0.317.
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O/E morbidity ratios were then calculated separately for elec-
tive and non-elective resections. For elective resections, this ratio
was 0.93; thus, outcomes for this group of patients were slightly
better than anticipated. For non-elective resections, the ratio was
1.00 and, therefore, matched expected standards. However, the
difference between elective and non-elective resections with
respect to O/E ratios was not statistically significant.
Deviation-based cost modelling
In order to describe the extent to which immediate preoperative
hospitalization alters the postoperative clinical course, outcomes
for elective and non-elective resections were further scrutinized
within the framework of our institutional standardized Carepath
for Pancreatic Resection. This analysis was conducted by employ-
ing DBCM, a validated quality analysis tool for measuring the
incremental impact of process improvement initiatives on hospi-
tal duration and costs. Overall, 61% of patients (n = 250) experi-
enced an unaltered clinical course (i.e. ‘on-course’). Deviations
occurred occasionally, but were usually classified as ‘minor devia-
tions’ (n = 65, 16%) or ‘moderate deviations’ (n = 56, 14%); ‘major
deviations’ occurred only 10% of the time (n = 41).
When outcomes for elective and non-elective resections were
juxtaposed, the incidence and severity of deviations was substan-
tially greater after non-elective cases (Table 6). Within each devia-
tion category, non-elective patients suffered longer hospital stays
and incurred greater costs, yet these differences were not statisti-
cally significant. However, the weighted-average for hospital
duration and costs distinguishes the full impact of complications
after elective and non-elective resections. The weighted-average
median hospital duration and costs after non-elective resections
were 10.8 days and $26 688, respectively; those after elective resec-
tions were 8.4 days and $19 608. Thus, the incremental impact
of complications after non-elective resections was roughly a 2-day
increase in hospital duration and a $7000 cost-increase per
patient.
Discussion
Standardized peri-operative clinical pathways have emerged as an
effective method to minimize variations in care, reduce duration
of stay, curtail excessive resource utilization and improve overall
cost-efficiencies.1–6 The putative benefits of these management
approaches have been described in the clinical literature, although
most of these findings are derived from non-randomized com-
parison studies, with Level II evidence at best.7–15 In one particular
study, Pritts et al. describe their experience with the development
and implementation of a clinical pathway for small and large
bowel resection.8 Their work uniquely compares a pathway group
with ‘both’ a pre-pathway group and a non-pathway group
(patients in the year after pathway implementation, but not
Table 6 Deviation-Based Cost Modelling (DBCM) for comparison of elective and non-elective pancreatic resections
DBCMa Elective (n = 373) Non-elective (n = 39) P-value
Deviation mix (%)
On-course 234 (63) 16 (41) 0.040
Minor deviation 57 (15) 8 (20)
Moderate deviation 46 (12) 10 (26)
Major deviation 36 (10) 5 (13)
On-course
Hospital duration 7 days 8 days 0.128
Post-operative hospital costs $16 782 $20 508 0.363
Minor deviation
Hospital duration 9 days 10 days 0.487
Total hospital costs $18 834 $21 562 0.792
Moderate deviation
Hospital duration 14 days 14 days 0.884
Post-operative hospital costs $27 703 $31 725 0.925
Major deviation
Hospital duration 9 days 15 days 0.159
Post-operative hospital costs $28 864 $44 591 0.852
Hospital duration (weighted-average) 8.4 10.8 –
Duration of stay increase (for non-elective cases) 2.4
Hospital costs (weighted-average) $19 608 $26 688 –
Cost increase (for non-elective cases) $7 079
aDescribed in full detail by Vanounou et al.15
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included on the pathway). Significant differences between the
groups were observed with respect to duration of stay and costs.
Pathway patients experienced shorter hospital stays and consider-
able cost-savings, as compared with non-pathway patients. These
findings have been reproduced in other studies and support the
use of clinical pathways for many surgical procedures.
Our group has previously published its experience with a clini-
cal Carepath for Pancreatic Resection. In this analysis, pathway
implementation contributed to a 1-day ‘decrease’ in median
hospital stay and $5500 cost-savings per patient.15 DBCM,
however, reveals that these improvements were achieved through
reductions in pathway deviations. As fewer deviations occurred
overall, more patients remained ‘On Course’; this improvement in
the deviation mix was associated with parallel reductions in
median hospital duration and costs. Deeper analysis demonstrates
that one-half of the overall cost-savings could be attributed spe-
cifically to pathway implementation; the remainder was associated
with general process and system improvements in surgical care
independent of the clinical pathway (i.e. secular trends).
Through this rigorous analysis, we realized that a distinct subset
of patients requires pre-operative hospitalization immediately for
peri-pancreatic complications, such as gastric outlet obstruction,
malignant biliary obstruction, malnutrition, hypovolemia and
gastrointestinal bleeding immediately preceding pancreatic resec-
tion. Like most clinical pathways, our Carepath for Pancreatic
Resection is based on evidence-based guidelines for patients
undergoing ‘elective’ pancreatic operations; it had not been evalu-
ated exclusively for non-elective resections, nor have others. Con-
sequently, it remained unclear whether immediate pre-operative
hospitalization and the ensuing non-elective resection negatively
influence the post-operative clinical course. Therefore, we sought
to describe the impact of pre-operative hospitalization on opera-
tive performance and the extent to which non-elective resection
results in post-operative deviations under the framework of a
standardized clinical pathway.
A detailed analysis of the non-elective operative scenario was
conducted and demonstrates that patients that require immediate
pre-operative hospitalization comprise 10% of all pancreatic
resections. These patients frequently had pancreatitis, gastric
outlet obstruction, intractable abdominal pain, gastrointestinal
bleeding and jaundice, which prompted early therapeutic inter-
vention, including intravenous antibiotics, supplemental
parenteral nutritional support, blood transfusion and endoscopic
procedures to facilitate biliary or pancreatic enteric drainage.
Despite more patients being younger and harbouring benign
pathologic conditions, these patients were sicker. Pre-operative
hospitalization at our institution alone was approximately 1 week
in duration and typically cost more than $7000; yet, it did not
significantly improve pre-operative patient acuity metrics.
Although patients presenting for non-elective resections demon-
strated greater patient acuity, this fact did not influence operative
performance measures. All operative outcomes for non-elective
resections were equivalent to those for elective cases, most notably
operative time and blood loss. Pre-operative hospitalization in
this scenario had no measurable impact on operative outcomes
and may, in fact, have helped safeguard against the natural pre-
disposition of these genuinely aggressive pancreatic pathological
conditions.
Post-operative complications occurred with significantly
higher frequency after non-elective pancreatic resections and
showed a trend towards greater severity. As a result, these patients
required more post-operative therapeutic interventions, such as
antibiotic therapy, supplemental parenteral nutritional support
and blood transfusion. More aggressive interventions were also
employed after non-elective resections, including ICU manage-
ment and reoperation. These differences are reflected by longer
postoperative hospital stays and costs, nearly $5000 more per
patient.
A contemporary O/E quality analysis demonstrates further that
although there was no significant difference between elective and
non-elective resections with respect to O/E ratios, surgical quality
for non-elective resections was on par with that of the elective
cohort, but did not exceed benchmark standards or surpass antici-
pated outcomes. This specific analysis indicates that improve-
ments in quality for non-elective resections can still be achieved.
DBCM was performed to determine whether immediate pre-
operative hospitalization and non-elective pancreatic resection
contribute to deviations in surgical care. DBCM demonstrates
that non-elective pancreatic resection alters the post-operative
clinical course, but does not significantly change the clinical and
economic nature of each pathway deviation. Overall, non-elective
patients suffered longer hospital stays and incurred greater costs;
yet, within each deviation category, these differences were not
statistically significant. Minor deviations behaved in a similar
fashion after elective and non-elective resections; as did moderate
and major deviations. Therefore, immediate pre-operative hospi-
talization and subsequent non-elective resection exact their influ-
ence on the postoperative clinical course by varying the incidence
of pathway deviations. This lone effect, overall, causes roughly a
2-day increase in hospital duration and a $7000 cost-increase per
patient.
While the findings of this study show a clear impact in terms of
the cost to the health care system for the non-elective scenario,
other limiting factors, which we could not adequately address,
may also be in play. For instance, it is unclear how many patients
presenting with pancreatic conditions are actually hospitalized
initially for definitive diagnosis and temporary management. In
our practice, 10% of patients were hospitalized immediately prior
to pancreatic resection; yet, this percentage underestimates the
true incidence of pre-operative hospitalization. We were unable to
precisely account for the patients, in either the elective or non-
elective cohort, who were hospitalized elsewhere at other medical
institutions prior to referral our surgical specialty center. One
might estimate that 15–20% of patients follow this pattern, but
this will vary across medical centres and among regional popula-
tions. Furthermore, the cost of outpatient assessments, diagnostic
64 HPB
HPB 2009, 11, 57–65 © 2009 International Hepato-Pancreato-Biliary Association
imaging and pre-operative palliative procedures performed at
other institutions contributes further to the cost-quality equation.
These costs, however, could not be included in our analysis. Nev-
ertheless, although these costs are relevant, we surmise that they
likely represent only a small fraction of the overall cost of surgical
care.
Going forward, process improvement initiatives, which target
the non-elective operative scenario, can – and will – be instrumen-
tal in streamlining patient care and maximizing cost-efficiency.
Patients requiring immediate pre-operative hospitalization may
have difficulty adhering to the stringent and structured guidelines
of a standardized clinical pathway and will potentially benefit from
efforts that reduce pathway deviations. For example, patients
at-risk for haemodynamic compromise, clinically relevant pancre-
atic fistulae and wound infection, who undergo non-elective
pancreatic resection, should be managed proactively in the peri-
operative period. This is particularly important in an era where,
because of the pressures for regionalization of expertise in care,
high-volume specialty surgical centers can expect more hospital-
to-hospital transfers for urgent management of peripancreatic
conditions.
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